
Psychiatr Serv 52:1081-1087, August 2001
© 2001 American Psychiatric Association
Prescription of Psychotropic Medications to Youths in Office-Based Practice
Renee Goodwin, Ph.D.,
Madelyn S. Gould, Ph.D., M.P.H.,
Carlos Blanco, M.D., Ph.D. and
Mark Olfson, M.D., M.P.H.
OBJECTIVE: This study sought to determine sociodemographic characteristics of treatment of children and adolescents for whom psychotropic medications are prescribed and to describe the clinical management approaches associated with the prescription of each major class of psychotropic medication in office-based medical practices in the United States. METHODS: Data for a four-year period (1992-1996) were drawn from the National Ambulatory Medical Care Survey, a nationally representative survey of office-based medical practices, to determine prescribing patterns, patients' sociodemographic characteristics, and clinical management approaches associated with visits during which psychotropic medications were prescribed to patients aged 19 years or under. RESULTS: Psychotropic medications were prescribed during 2.2 percent of all visits. A majority of the prescriptions for psychotropic medications (84.8 percent) were provided by general practitioners or pediatricians. For the visits during which a psychotropic medication was prescribed, stimulants were the most commonly prescribed (53.9 percent of such visits), but prescription of other classes of medications was not uncommon: antidepressants (30 percent), anxiolytics (7.2 percent), antipsychotics (7.2 percent), and mood stabilizers (12.7 percent). Significant differences were observed in the prescription of each class of medication by sex, race, and payment source. CONCLUSIONS: General practitioners and pediatricians have a role in the office-based treatment of youths with psychotropic medications.
This article has been cited by other articles:

|
 |

|
 |
 
J. D. McLeod, D. L. Fettes, P. S. Jensen, B. A. Pescosolido, and J. K. Martin
Public Knowledge, Beliefs, and Treatment Preferences Concerning Attention-Deficit Hyperactivity Disorder
Psychiatr Serv,
May 1, 2007;
58(5):
626 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Case, M. Olfson, S. C. Marcus, and C. Siegel
Trends in the Inpatient Mental Health Treatment of Children and Adolescents in US Community Hospitals Between 1990 and 2000
Arch Gen Psychiatry,
January 1, 2007;
64(1):
89 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Hazel-Fernandez, R. Klorman, J. M. Wallace, and S. Cook
Methylphenidate improves aspects of executive function in african american children with ADHD.
J Atten Disord,
May 1, 2006;
9(4):
582 - 589.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Fedorowicz and E. Fombonne
Metabolic side effects of atypical antipsychotics in children: a literature review
J Psychopharmacol,
September 1, 2005;
19(5):
533 - 550.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Zito, D. J. Safer, I. H. Zuckerman, J. F. Gardner, and K. Soeken
Effect of Medicaid Eligibility Category on Racial Disparities in the Use of Psychotropic Medications Among Youths
Psychiatr Serv,
February 1, 2005;
56(2):
157 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Conrad
Prescribing More Psychotropic Medications for Children: What Does the Increase Mean?
Arch Pediatr Adolesc Med,
August 1, 2004;
158(8):
829 - 830.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Warner, K. J. Pottick, and A. Mukherjee
Brief Reports: Use of Psychotropic Medications by Youths With Psychiatric Diagnoses in the U.S. Mental Health System
Psychiatr Serv,
March 1, 2004;
55(3):
309 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Olfson, M. J. Gameroff, S. C. Marcus, and B. D. Waslick
Outpatient Treatment of Child and Adolescent Depression in the United States
Arch Gen Psychiatry,
December 1, 2003;
60(12):
1236 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Martin, T. Van Hoof, D. Stubbe, T. Sherwin, and L. Scahill
Multiple Psychotropic Pharmacotherapy Among Child and Adolescent Enrollees in Connecticut Medicaid Managed Care
Psychiatr Serv,
January 1, 2003;
54(1):
72 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Zito, D. J. Safer, S. dosReis, J. F. Gardner, L. Magder, K. Soeken, M. Boles, F. Lynch, and M. A. Riddle
Psychotropic Practice Patterns for Youth: A 10-Year Perspective
Arch Pediatr Adolesc Med,
January 1, 2003;
157(1):
17 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Zito, D. J. Safer, S. dosReis, J. F. Gardner, K. Soeken, M. Boles, and F. Lynch
Rising Prevalence of Antidepressants Among US Youths
Pediatrics,
May 1, 2002;
109(5):
721 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Storch
Prescriptions of Medications to Youths
Psychiatr Serv,
February 1, 2002;
53(2):
214 - 215.
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2001
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|